Insulin Pumps Market Share, Competitor’s Analysis, Supply and Consumption 2020 Research Report Forecast To 2025
Increasing prevalence of type I diabetes is driving the market for insulin pumps over the forecast period
According to The Insight Partners market
research study titled “Insulin Pumps Market to 2025 – Global Analysis and Forecasts by Product, Type and
Application”, the global insulin pumps market was valued at US$ 3,822.44 Mn in
2017 and is estimated to reach US$ 8,264.01 Mn by 2025. The report highlights
the trends prevalent in the global insulin pumps market and the factors driving
the market along with those that act as deterrents to its growth.
The increasing technological advancements due
to the increased demand for product development. However, the availability of
alternatives for insulin delivery pumps are expected to act as major challenges
hindering the market growth.
The global insulin pumps market is a mature
market in the developed countries as well as in developing economies worldwide.
The insulin pumps market is segmented on the basis of product, type and
application. Based on product, the market is bifurcated into pumps and
accessories. By type, the insulin pumps market is segmented into tethered and
untethered types. On the basis of application segment, the market is classified
as type I diabetes and type II diabetes. The insulin pumps include the
applications such as type I diabetes and type II diabetes. The insulin pumps by
application, the dominance of type I diabetes segment attributes to the
alleviation from large costs that are incurred by the companies for in-house
activities.
Explore Premium Report on Insulin
Pumps Market at: https://www.theinsightpartners.com/sample/TIPHE100001290/
The factors that are responsible for the type
I diabetes include genetics, exposure to viruses and other environmental
factors that develops in adults but also typically appears during childhood or
adolescence phase. According to the Centers for Disease Control and Prevention
(CDC), in 2017, approximately 23 million people had diagnosed with diabetes in
the United States, whereas people with type I diabetes accounted for
approximately 5% to 10%, or approximately 1.2 to 2.3 million in the country.
Furthermore, the IDF also projected with type I diabetes that represent
approximately 10% of the diabetes population worldwide. Thus, the increasing
prevalence of type I diabetes help to boost the growth of the global insulin
market in the coming years.
Over the years, researchers have been carrying
out research activities which have resulted to product innovations. Products
with increased technology with more effective benefits is a major requirement
in the treatment for diabetes. As the prevalence of diabetes is increasing
across the world, the demand for more products with advancements is also
boosting up. The growing innovations in novel insulin pump products is a
boosting factor that helps to propelling the growth for the market.
For instance, in July 2018, the Roche received
a CE mark for its Accu-Chek Solo micropump system. The system is a small
tube-free insulin delivery device that offers to their users the choice to
bolus directly from the pump. It is fully functional handheld device that
comprise detach and re-attach function of pump without wasting insulin. The
Accu-Chek Solo micropump integrates and the Roche’s digital health solutions
contributing in a combination to provide more effective and personalized
diabetes management to their users. Moreover, in the March 2018, the Medtronic
announced to have a FDA approval for their latest smart technology of
standalone CGM named the Guardian Connect system. The Guardian Connect system
has the advanced feature including alert system that helps in aware people
about potential high or low glucose level events, up to 60 minutes in advance.
The key players operating in the field of
insulin pumps market worldwide include Insulet Corporation, Medtronic, Tandem
Diabetes Care, Inc, Debiotech S.A, CELLNOVO, SOOIL Developments Co., Ltd,
MicroPort, Scientific Corporation, Valeritas Inc., F. Hoffmann-La Roche Ltd.,
Ypsomed AGand and among others.
About Us:
The Insight Partners is a one stop industry research provider
of actionable intelligence. We help our clients in getting solutions to their
research requirements through our syndicated and consulting research services.
We specialize in industries such as Semiconductor and Electronics, Aerospace
and Defense, Automotive and Transportation, Biotechnology, Healthcare IT,
Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would
like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Comments
Post a Comment